The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
Abstract
Objective To describe the pattern of development of incidence of multiple sclerosis (MS) over 60 years in Denmark with age-period-cohort analyses and seasonality of birth. Methods Data on virtually all patients with onset of MS have since 1950 been prospectively recorded and kept in the Danish Multiple Sclerosis Registry with multiple sources of notification. Annualized incidence rates per 100,000 were directly standardized to the European Standard Population. Results We have registered 19,536 cases with clinical onset of confirmed MS in Denmark from 1950 to 2009. From the 1950-1959 to the 2000-2009 onset period, incidence more than doubled in women, with an increase from 5.91 (95% confidence interval [CI]: 5.60-6.24) to 12.33 (95% CI: 11.91-12.75) per 100,000 per year compared with a modest 24% increase in men from 4.52 (95% CI: 4.24-4.81) to 6.08 (95% CI: 5.79-6.38). With age at onset of 50 years and older, incidence increased with a factor 4.30 in women and 2.72 in men. The female/male sex ratio increased over time and with year of birth. Age-period-cohort analysis revealed a significant birth cohort effect in addition to the age and period effect. We found no statistically significant seasonality of births. Conclusion The incidence of MS has doubled in women, most pronounced with late onset, and has only modestly increased in men. Lifestyle changes in the female population that could include fewer childbirths, increased occurrence of obesity, and increased cigarette consu…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of data from the Danish Multiple Sclerosis Registry showed that incidence in women doubled between 1950 and 2009, whereas increases among men have been more modest.31”
From Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) · cites this paper as [31]
In the citing paper
“Environmental changes that might be contributing to the rapid change in incidence among women include the rise in obesity, increased cigarette smoking, and changes in the frequency of breastfeeding infants.31, 33”
From Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) · cites this paper as [31]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
The Danish Civil Registration System
Pedersen, C. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,713
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
RE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
Halperin, M. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112409 · Cited by 1,546
ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES
Miettinen, O. S. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112220 · Cited by 1,322
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Self-citationModels for temporal variation in cancer rates. II: Age–period–cohort models
Clayton, D. G., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060406 · Cited by 922
A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates
Rosenberg, P. S., Check, D. P., & Anderson, W. F. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0300 · Cited by 825
Temporal trends in the incidence of multiple sclerosis
Alonso, Á., & Hernán, M. Á. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 695
Research works printed but not linked: 3
- Hyllested K. Disseminated Sclerosis in Denmark: Prevalence and Geographical Distribution [doctoral thesis]. Copenhagen: J. Jørgensen; 1956.
- Allison RS, Millar JDH. Prevalence and familial incidence of disseminated sclerosis. Ulster Med J 1954;23(suppl 2):1–92.
- 10.1111/ane.12615 · DOI
Cited by
Sorted by citations
Items 101–190 of 190
Moles, L., Otaegui-Chivite, A., Gorostidi-Aicua, M., Romarate, L., Mendiburu, I., Crespillo-Velasco, H., de Arcaya, A. Á., Ferreira, E., Arruti, M., Castillo‐Triviño, T., et al. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00457 · Cited by 8
Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021
Nielsen, J. J. J., Levison, L. S., & Andersen, H. (2024) · Neurology · doi:10.1212/wnl.0000000000210139 · Cited by 8
Rasmussen, N. F., Rubin, K. H., Stougaard, M., Tjønneland, A. M., Stenager, E., Hetland, M. L., Glintborg, B., Bygum, A., & Andersen, V. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024555 · Cited by 8
Self-citationBranigan, G. L., Torrandell‐Haro, G., Vitali, F., Brinton, R. D., & Rodgers, K. E. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11196 · Cited by 8
Infectious mononucleosis is a more realistic target for preventing multiple sclerosis
Giovannoni, G., Hawkes, C. H., Lechner‐Scott, J., Yeh, E. A., & Levy, M. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106337 · Cited by 7
Skarlis, C., Papadopoulos, V., Raftopoulou, S., Mavragani, C. P., & Evangelopoulos, M. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109847 · Cited by 7
Pharmacotherapeutic considerations in women with multiple sclerosis
Andersen, J. B., & Magyari, M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1774554 · Cited by 7
Self-citationBergien, S. O., Siersma, V., Kristiansen, M., & Skovgaard, L. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104878 · Cited by 7
Is the incidence of multiple sclerosis really increasing?
Hawkes, C. H., Giovannoni, G., Lechner‐Scott, J., & Levy, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102527 · Cited by 9
Incidence of late onset multiple sclerosis in Italy: a population-based study
Cicero, C. E., Chisari, C. G., Salafica, G., Fermo, S. L., Donzuso, G., Maimone, D., Marziolo, R., Patti, F., & Nicoletti, A. S. Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-81284-3 · Cited by 6
Zarobkiewicz, M. K., Morawska, I., Kowalska, W., Halczuk, P., Roliński, J., & Bojarska-Junak, A. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113210 · Cited by 6
Sadovnick, A. D., Yee, I. M. L., Criscuoli, M. G., & DeLuca, G. C. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211020221 · Cited by 7
Margarit, B. P., Monteiro, G. C., Herán, I. S., Delgado, F. R., & Izquierdo, A. Y. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.05.010 · Cited by 9
Jacober, S. L. S., Disanto, G., Sacco, R., Meng, D., Mallucci, G., Candrian, U., Semini, S., Tiberti, M., Gobbi, C., & Zecca, C. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231199820 · Cited by 5
Changes in the sex ratio are a good indicator of changes in MS incidence – No
Magyari, M., & Koch‐Henriksen, N. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519837926 · Cited by 5
Self-citationBergien, S. O., Skovgaard, L., & Kristiansen, M. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04504-x · Cited by 5
Bufan, B., Ćuruvija, I., Blagojević, V., Grujić-Milanović, J. D., Prijić, I., Radosavljević, T. S., Samardžić, J., Radosavljević, M., Janković, R., & Djuretić, J. (2024) · Biomedicines · doi:10.3390/biomedicines12040717 · Cited by 5
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progression
Otaegui-Chivite, A., Gorostidi-Aicua, M., Martins-Almeida, L., Alberro, A., Romarate, L., Mendiburu, I., de Arcaya, A. Á., Arruti, M., Castillo‐Triviño, T., Otaegui, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625794 · Cited by 4
Alomair, O. I., Alghamdi, S. A., Abujamea, A. H., Aljarallah, S., Alkhawajah, N. M., Alshuhri, M. S., Alashban, Y. I., & Kurniawan, N. D. (2025) · Diagnostics · doi:10.3390/diagnostics15162113 · Cited by 5
Updated Multiple Sclerosis Incidence in France, 2011–2021
Guinebretiere, O., Pierret, C., Calonge, Q., Januel, É., Louapre, C., & Nédelec, T. (2025) · Neurology · doi:10.1212/wnl.0000000000213586 · Cited by 7
Changes in the sex ratio are a good indicator of changes in MS incidence – Yes
Ajdacic‐Gross, V., & von Wyl, V. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519838780 · Cited by 4
Association of CD58 polymorphism and multiple sclerosis in Malaysia: a pilot study
Ching, Y. M., Viswanathan, S., Nor, N. M., Shuib, S., Kamarudin, B., Mansor, S., Yusof, A. Y., & Arip, M. (2019) · Autoimmunity Highlights · doi:10.1186/s13317-019-0123-7 · Cited by 4
Michelis, D., Brunetti, N., Solaro, C. M., Mancardi, G., Uccelli, A., Inglese, M., & Laroni, A. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104464 · Cited by 4
Wandall‐Holm, M. F., Holm, R. P., Pontieri, L., Sellebjerg, F. T., & Magyari, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1214897 · Cited by 4
Self-citationPrzybek-Skrzypecka, J., Małecka, I., Członkowska, A., & Mirowska-Guzel, D. M. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0027 · Cited by 4
Late-onset multiple sclerosis from a different angle
Prosperini, L., & Haggiag, S. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241249901 · Cited by 4
Exploring the Complexity of Falls in People With Multiple Sclerosis: A Qualitative Study
Wäneskog, A. H., Forsberg, A., & Nilsagård, Y. E. (2024) · International Journal of MS Care · doi:10.7224/1537-2073.2024-020 · Cited by 3
Cayuela, L., García‐Muñoz, C., & Cayuela, A. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07899-6 · Cited by 3
Moles, L., Konings, M. C. J. M., Bravo-Miana, R. D. C., Crespillo-Velasco, H., Prada, A. J., Castillo‐Triviño, T., Plat, J., & Otaegui, D. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107143 · Cited by 3
Adult-onset and late-onset multiple sclerosis in older adults in a Finnish university hospital
Ahtinen, K., Korhonen, I., Kuusisto, H., & Rauma, I. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08756-w · Cited by 3
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis
Mærsk-Møller, C. C., Pontieri, L., Stilund, M., Christensen, J. R., Storr, L. K., Hansen, V., Schäfer, J., Wêglewski, A., Romani, K. Q., Jensen, H. B., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70507 · Cited by 3
Self-citationImpact of sex on multiple sclerosis therapy
Coyle, P. K. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00620 · Cited by 2
Solaro, C. M., Pretti, N., & Uccelli, M. M. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106701 · Cited by 2
Incidence and prevalence of multiple sclerosis in Qatar: A population-based study from 2016 to 2024
AbuAlrob, M. A., Khodair, R., Ibrahim, F. M., Hamid, S., SULIMAN, O., Zammar, K., Abdelmoneim, M. S., Perkins, J. D., & Canibaño, B. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107415 · Cited by 2
Prediction in treatment outcomes in multiple sclerosis: challenges and recent advances
Rose, D. R., Amin, M., & Ontaneda, D. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1986005 · Cited by 2
Influence of Primary Neurologic Disease on Cardiovascular Health in Females
Ali, K. A., Kerrigan, D. L. G., & Berkman, J. (2025) · Circulation Research · doi:10.1161/circresaha.124.325545 · Cited by 2
Tendencias de la mortalidad por esclerosis múltiple en España de 1981 a 2020
Cayuela, L., de Albóniga-Chindurza, A., Gómez-Enjuto, S., Lapeña-Motilva, J., de la Maza, S. S., García, A. G., & Cayuela, A. (2025) · Neurología · doi:10.1016/j.nrl.2023.06.014 · Cited by 2
Estudo epidemiológico das doenças neurodegenerativas na Região da Guarda - Portugal
Marques, E. M. G. B., Paulino, M. D. N. S., de Paiva, T. M. D., Corte, A. E. D. M., & Fonseca, M. C. P. M. (2023) · Global Academic Nursing Journal · doi:10.5935/2675-5602.20200338 · Cited by 2
Geochemistry of multiple sclerosis in Finland
Roos, P. M., & Åström, M. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.121072 · Cited by 2
Nordic clues for uncovering the aetiology of Multiple Sclerosis
Sipilä, J. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102804 · Cited by 2
Rashed, A. B., Mostafa, S. S., Amer, N. A., Badawy, S. A., Hussein, A. A., & Nada, H. E. A. E.-R. (2023) · doi:10.56984/8zg20b3c3 · Cited by 1
Epidemiology of multiple sclerosis in the city of Novosibirsk
Евгеньевич, А. И., Ивановна, П. А., Tretyakova, E. V., Korobko, D. S., & Malkova, N. A. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2025125011119 · Cited by 1
Tamaš, O., Veljancic, N., Kovačević, M., Veselinovic, N., Budimkic, M. S., Momčilović, N., Andabaka, M., & Mesaroš, Š. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02844-6 · Cited by 1
Innate immunity and biomarkers of multiple sclerosis relapse versus remission
Karadeniz, M., Wesselingh, R., Jayakrishnan, P. C., Sequeira, R. P., van der Walt, A., Butzkueven, H., & Monif, M. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104058 · Cited by 1
Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions
He, J., Blackburn, N. B., & Jokubaitis, V. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-01009-8 · Cited by 1
Guío‐Sánchez, C., Carrillo-Martínez, J. C., Duarte, L., Zuluaga, M. E., Acosta, H., López-Reyes, L., Arenas-Vargas, L. E., & Cárdenas‐Robledo, S. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106592 · Cited by 2
Declerck, L., Ginis, K. M., Cheung, A., Jeng, B., Zheng, P., Huynh, T. L. T., Brunskill, A., & Motl, R. W. (2026) · Systematic Reviews · doi:10.1186/s13643-026-03095-z · Cited by 1
Oreja‐Guevara, C., Meuth, S. G., Grigoriadis, N., Vermersch, P., Hartung, H. P., Sørensen, P. S., Leocani, L., Schmierer, K., Gold, R., & Fernandez, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1832582 · Cited by 1
Epidemiology of Multiple Sclerosis and Environmental Risk Factors
McKay, K. A., & Tremlett, H. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_10 · Cited by 1
Overcome treatment-resistance in breast cancer cells: Review
Saleh, N. K., Nazar, A.-K. M., & Ibrahim, R. (2023) · AIP conference proceedings · doi:10.1063/5.0103979 · Cited by 1
Economic and Disease Burden of Multiple Sclerosis in Colombia
Lozano, A. M., Gutiérrez-Clavijo, J. C., Pineda-Lozano, J. C., Cárdenas‐Robledo, S., Vanegas, A. C., & Alvis-Zakzuk, N. J. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101096 · Cited by 1
Paul, F. (2019) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-030-13550-8_9 · Cited by 1
Patient-perceived risks of MS DMTs
McDonnell, G. V., & Marriott, J. J. (2019) · Neurology · doi:10.1212/wnl.0000000000007230 · Cited by 1
Free health care, great data, and new clues on multiple sclerosis
Franklin, G. M., & McDonnell, G. V. (2018) · Neurology · doi:10.1212/wnl.0000000000005593
Koch‐Henriksen, N. (2019) · Neurology · doi:10.1212/wnl.0000000000006944
Self-citationChanges in the sex ratio are a good indicator of changes in MS incidence – Commentary
Pugliatti, M. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519845114
Multiple Sklerose: Erstdiagnose im höheren Lebensalter
Kristoferitsch, W. (2019) · psychopraxis neuropraxis · doi:10.1007/s00739-019-0576-5
Petersen, L. S., & Sorknæs, A. D. (2019) · Edorium Journal of Disability and Rehabilitation · doi:10.5348/100046d05lp2019ra
Jokubaitis, V., & Dobson, R. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520907902
A hazai sclerosis multiplex betegpopuláció életkori és nemi megoszlása 2004 és 2016 között
Iljicsov, A., Bereczki, D., Dobi, B., Oberfrank, F., Bálint, M., Ajtay, A., Milanovich, D., & Simó, M. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32100
Factors determining the treatment ineffectiveness in multiple sclerosis
Güler, S. (2021) · Neurological Research · doi:10.1080/01616412.2021.1967680
Hawkes, C. H., Giovannoni, G., Levy, M. L., & Waubant, E. L. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.08.010
Arzneimittelversorgung bei Multipler Sklerose
Paul, F., & Berthele, A. (2022) · Springer eBooks · doi:10.1007/978-3-662-66041-6_9
AGING, A PATHOLOGICAL FACTOR IN NEUROLOGICAL INJURY
Vijikumar, A. (2022) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11613
Diffusion Tractography in Neurosurgical Planning: Overview of Advanced Clinical Applications
Miao, J., Feuerwerker, S., Hafazalla, K., Janczewski, L. M., Baldassari, M. P., Lange, S., Manmatharayan, A., Muller, J., Kogan, M., Matias, C. M., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_41
Multiple Sklerose: Besonderheiten im höheren Alter
Motte, J., & Gold, R. (2023) · Deutsches Ärzteblatt · doi:10.3238/persneuro.2023.12.15.01
Moreira, Á. J. P. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2024.tde-26072024-135934
The Influence of Gender on Diseases of the Nervous System: A Narrative Review
Soluki, M., Momen, L. T., Mahmoudi, F., & Abdolmaleki, A. (2025) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.61186/jrums.24.1.80
Relationship of cranial bone signal intensity to multiple sclerosis clinical course and progression
Sarıdaş, F., Özpar, R., Özdemir, Ü., Dinç, Y., Akarsu, E. O., Koç, E. R., Özkaya, G., Hakyemez, B., & Turan, Ö. F. (2025) · Science Progress · doi:10.1177/00368504251336090
Matsushita, T. (2025) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.70015 · Cited by 1
Multiple sclerosis mortality trends in Spain from 1981 to 2020
Cayuela, L., de Albóniga-Chindurza, A., Gómez-Enjuto, S., Lapeña-Motilva, J., de la Maza, S. S., García, A. G., & Cayuela, A. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.06.006
Response to therapy in a cohort of patients with late-onset multiple sclerosis
Ahmad, S., Graham, E. L., Lancki, N., Caldito, N. G., Perez-Giraldo, G., & Cohen, B. A. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251360357
Trends in prevalence and incidence of multiple sclerosis in the Israeli Jewish and Arab populations
Spierer, R., Hurani, M., Stein, N., Rawashdeh, A., Bloch, S., & Golan, D. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123721
Wimberley, T., Horsdal, H. T., Brikell, I., Laursen, T. M., Astrup, A., Fanelli, G., Bralten, J., Poelmans, G., van Gils, V., Jansen, W. J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20677990
Bergien, S. O., Skovgaard, L., & Kristiansen, M. (2023) · Figshare · doi:10.6084/m9.figshare.24715489
Arkhipov, I. E., Prokaeva, A. I., Korobko, D. S., & Malkova, N. A. (2025) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2025-9-4-80-90
The cutaneous silent period in multiple sclerosis
Elhadidy, R., Kotb, S. M., Labib, A. A., Fouad, A. M., & Khalil, A. S. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-01059-z
Adnan, R., Samadzadeh, S., Richter, C., Möller, S., Roikjær, S. G., Frølich, A., Skou, S. T., Dalgas, U., & Asgari, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1625017
Kekenadze, M., Vashadze, S., Saparidze, K., Gorgiladze, K., & Varshanidze, K. (2026) · Georgian Medical Journal · doi:10.66636/gmj.v1.i2.a111
Menopause and ageing in women with multiple sclerosis
Simonsen, C. S., & Celius, E. G. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1838550
Khayat-Khoei, M., Houtchens, M. K., & Khoury, S. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00078-0
Naydovich, L. R., & Berger, J. R. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107374
Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations
Aboseif, A., Zeydan, B., Nathoo, N., Kantarci, O. H., Amezcua, L., Voskuhl, R. R., Bove, R. M., Hua, L. H., Ontaneda, D., Conway, D. S., et al. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107389
Blanca-Serrano, T., Agredano-Sanchez, M., Gigosos, R. M. L., Navarro, M. F. J., González-Domenech, C. M., & Gutiérrez‐Bedmar, M. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106747
Shared etiology of late- and adult-onset multiple sclerosis
Karrenbauer, V. D., Olsson, T. P., Alfredsson, L. S., & Hedström, A. K. (2026) · Multiple Sclerosis Journal · doi:10.1177/13524585261472320
Nicoletti, A. S. Q., Cicero, C. E., Chisari, C. G., Fermo, S. L., Donzuso, G., Manno, F., Maimone, D., Marziolo, R., Zappia, M., & Patti, F. (2026) · Neuroepidemiology · doi:10.1159/ned/adwag012
Zúnica‐García, S., Pastor-Vidal, B., Gracia‐Sánchez, A., Jiménez‐Trujillo, I., Chicharro‐Luna, E., & Sempere, Á. P. (2026) · Foot & Ankle Specialist · doi:10.1177/19386400261484267
Mohamed, M. I., Thabet, M. Y., Nasr, N., & Nada, M. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107965
Metadata
- Authors
- Koch-Henriksen, N., Thygesen, L. C., Stenager, E., Laursen, B., & Magyari, M.
- Affiliations
- From the Clinical Institute (N.K.-H.), Department of Clinical Epidemiology, University of Aarhus; Danish Multiple Sclerosis Registry (N.K.-H., E.S., M.M.) and Department of Neurology (M.M.), Rigshospitalet, University of Copenhagen; National Institute of Public Health (L.C.T., B.L.), University of Southern Denmark in Copenhagen; Institute of Regional Health Research (E.S.), University of Southern Denmark, Odense.
- University of Copenhagen (DK)
- Venue
- Neurology
- Published
- 2018-05-29
- Volume
- 90
- Issue
- 22
- Pages
- e1954-e1963
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2799594477
- Cited by
- 188
- References
- 45
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 23 · 2023: 25 · 2022: 27 · 2021: 19 · 2020: 21 · 2019: 25 · 2018: 6
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Climate Change and Health Impacts
- Keywords
- multiple sclerosis, incidence trends, sex differences, late-onset multiple sclerosis, birth cohort effects, birth seasonality, age-period-cohort analysis, lifestyle factors, Denmark
- MeSH terms
- Adult, Denmark, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Prospective Studies, Registries, Sex Factors, Incidence, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review